TASK: REFINE ADRD CLASSIFICATION WITH CLINICAL GUIDELINES

You previously extracted clinical data for ADRD classification. Now refine your assessment using authoritative clinical guidelines and diagnostic criteria.

ORIGINAL CLINICAL TEXT:
{clinical_text}

INITIAL CLASSIFICATION:
{stage3_json_output}

CLINICAL GUIDELINES AND EVIDENCE:
{retrieved_evidence_chunks}

═══════════════════════════════════════════════════════════════════════════
REFINEMENT OBJECTIVES
═══════════════════════════════════════════════════════════════════════════

1. **VALIDATE CRITERIA APPLICATION**
   - Review NIA-AA 2011/2018 criteria against your classification
   - Ensure DSM-5 major/mild neurocognitive disorder criteria met
   - Check specific criteria for VaD, LBD, FTD if applicable

2. **ENHANCE DIAGNOSTIC PRECISION**
   - Use retrieved MMSE/MoCA interpretation guidelines for severity staging
   - Apply CDR scoring guidelines for functional assessment
   - Reference imaging interpretation standards for atrophy patterns

3. **STRENGTHEN DIFFERENTIAL DIAGNOSIS**
   - Use guidelines to better distinguish ADRD subtypes (AD vs VaD vs LBD vs FTD)
   - Reference criteria for ruling out depression, delirium, MCI
   - Validate metabolic/reversible cause exclusion

4. **IMPROVE BIOMARKER INTERPRETATION** (if available)
   - Apply A/T/N framework (Amyloid/Tau/Neurodegeneration) for AD
   - Reference CSF biomarker cutoffs from guidelines
   - Integrate PET imaging interpretation standards

5. **REFINE CONFIDENCE ASSESSMENT**
   - High confidence: Meets all core criteria, supported by biomarkers/imaging
   - Moderate confidence: Meets clinical criteria, limited biomarker data
   - Low confidence: Atypical presentation, conflicting findings, missing data

═══════════════════════════════════════════════════════════════════════════
GUIDELINE-INFORMED REFINEMENTS
═══════════════════════════════════════════════════════════════════════════

Compare your initial assessment against guideline standards:

**COGNITIVE THRESHOLDS** (from retrieved guidelines):
- Review if cognitive test scores align with guideline-defined cutoffs
- Check if severity staging matches CDR/MMSE guideline ranges
- Validate domain-specific impairments against neuropsych norms

**FUNCTIONAL CRITERIA** (from retrieved guidelines):
- Ensure functional decline meets threshold for dementia vs MCI
- Validate ADL/IADL impairment against guideline definitions
- Check if decline interferes with independence per criteria

**TEMPORAL PATTERNS** (from retrieved guidelines):
- Verify onset/progression pattern matches guideline descriptions
- Insidious onset (AD) vs stepwise (VaD) vs fluctuating (LBD)
- Duration criteria met (symptoms >6 months typically)

**SUPPORTING FEATURES** (from retrieved guidelines):
- Biomarker interpretation against guideline cutoffs
- Imaging findings against guideline-defined patterns
- Behavioral symptoms against guideline BPSD descriptions

═══════════════════════════════════════════════════════════════════════════
REFINEMENT INSTRUCTIONS
═══════════════════════════════════════════════════════════════════════════

1. **DO NOT change classification unless guidelines reveal error**
   - Most refinements should enhance detail, not flip diagnosis
   - Only change ADRD ↔ Non-ADRD if clear guideline misapplication

2. **DO enhance specificity within ADRD**
   - Better distinguish AD vs VaD vs LBD vs FTD using guideline criteria
   - Improve severity staging precision using guideline cutoffs

3. **DO improve confidence justification**
   - Reference specific guideline criteria met/not met
   - Quantify certainty using guideline-based evidence strength

4. **DO add guideline-based recommendations** (if appropriate):
   - Suggest additional testing if guidelines indicate it would clarify diagnosis
   - Note if presentation warrants specialist referral per guidelines

═══════════════════════════════════════════════════════════════════════════

{json_schema_instructions}

Output refined classification with guideline-supported reasoning.
